<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hasler, Gregor</dc:creator>
  <dc:date>2020-06-19</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">In major depression, remission rate in response to monoaminergic antidepressant is  around 50%. The lack of strong synergies between classical antidepressants and  psychotherapy may be due to the molecular effects of classical antidepressants. They  modulate synapses but they do not substantially influence synaptogenesis. They also  increase brain-derived neurotrophic factor (BDNF). However, for activity-dependent  plasticity, BDNF release has to work in concert with activation of synaptogenesis.  There has been considerable excitement about ketamine’s antidepressant effect.  Ketamine leads to fast changes in synaptic function and plasticity that go well beyond  effects of classical antidepressants. As a result, ketamine may turn out to have the  capacity to considerably enhance the effects of psychotherapy. Such enhancing  effects may become an important clinical indication for ketamine since its purely  pharmacological effect is transient. This editorial outlines some mechanistic  hypotheses, how Behavioral Activation, Trauma-Focused Psychotherapies and  Humanistic Psychotherapy may specifically prolong ketamine’s antidepressant effects.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/unifr/documents/308768</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308768/files/has_tsw.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1017/S1092852919001007</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>CNS Spectrums. - 2020, vol. 25, no. 3, p. 445–447</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Toward specific ways to combine ketamine and psychotherapy in treating depression</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
